{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T22:08:52Z","timestamp":1790892532173,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Guiding Science and Technology Project of Tongxiang City","award":["202202176"],"award-info":[{"award-number":["202202176"]}]},{"name":"Science and Technology Project of Tongxiang City","award":["202302249"],"award-info":[{"award-number":["202302249"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-20949-z","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T16:34:00Z","timestamp":1759250040000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Dihydroartemisinin ameliorates renal tubulointerstitial fibrosis in diabetic nephropathy via restoring mitochondrial function via HIF-1\u03b1\/HO-1 pathway"],"prefix":"10.1038","volume":"15","author":[{"given":"Yuan","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Fei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingling","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,30]]},"reference":[{"key":"20949_CR1","doi-asserted-by":"crossref","unstructured":"Samsu, N. Diabetic Nephropathy: Challenges in Pathogenesis, Diagnosis, and Treatment. Biomed Res Int 1497449. (2021).","DOI":"10.1155\/2021\/1497449"},{"key":"20949_CR2","doi-asserted-by":"publisher","first-page":"114897","DOI":"10.1016\/j.biopha.2023.114897","volume":"164","author":"Z Liu","year":"2023","unstructured":"Liu, Z. et al. Endoplasmic reticulum stress-triggered ferroptosis via the XBP1-Hrd1-Nrf2 pathway induces EMT progression in diabetic nephropathy. Biomed. Pharmacother. 164, 114897 (2023).","journal-title":"Biomed. Pharmacother"},{"key":"20949_CR3","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1142\/S0192415X22500744","volume":"50","author":"XJ Liu","year":"2022","unstructured":"Liu, X. J. et al. A review of traditional Chinese medicine on treatment of diabetic nephropathy and the involved mechanisms. Am. J. Chin. Med. 50, 1739\u20131779 (2022).","journal-title":"Am. J. Chin. Med."},{"key":"20949_CR4","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1016\/j.cmet.2021.04.004","volume":"33","author":"Y Mori","year":"2021","unstructured":"Mori, Y. et al. KIM-1 mediates fatty acid uptake by renal tubular cells to promote progressive diabetic kidney disease. Cell. Metab. 33, 1042\u20131061e1047 (2021).","journal-title":"Cell. Metab."},{"key":"20949_CR5","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s00441-017-2754-1","volume":"372","author":"I Loeffler","year":"2018","unstructured":"Loeffler, I. et al. FSP1-specific SMAD2 knockout in renal tubular, endothelial, and interstitial cells reduces fibrosis and epithelial-to-mesenchymal transition in murine STZ-induced diabetic nephropathy. Cell. Tissue Res. 372, 115\u2013133 (2018).","journal-title":"Cell. Tissue Res."},{"key":"20949_CR6","doi-asserted-by":"publisher","first-page":"5787","DOI":"10.1002\/jcp.29512","volume":"235","author":"L Li","year":"2020","unstructured":"Li, L. et al. The effect of lncRNA-ARAP1-AS2\/ARAP1 on high glucose-induced cytoskeleton rearrangement and epithelial-mesenchymal transition in human renal tubular epithelial cells. J. Cell. Physiol. 235, 5787\u20135795 (2020).","journal-title":"J. Cell. Physiol."},{"key":"20949_CR7","doi-asserted-by":"publisher","first-page":"111088","DOI":"10.1016\/j.cellsig.2024.111088","volume":"117","author":"F Wang","year":"2024","unstructured":"Wang, F., Zhang, Y., Gao, M. & Zeng, X. TMEM16A inhibits renal tubulointerstitial fibrosis via Wnt\/beta-catenin signaling during hypertension nephropathy. Cell. Signal. 117, 111088 (2024).","journal-title":"Cell. Signal."},{"key":"20949_CR8","doi-asserted-by":"publisher","first-page":"603","DOI":"10.7150\/ijbs.50364","volume":"17","author":"X Dai","year":"2021","unstructured":"Dai, X. et al. Dihydroartemisinin: A potential natural anticancer drug. Int. J. Biol. Sci. 17, 603\u2013622 (2021).","journal-title":"Int. J. Biol. Sci."},{"key":"20949_CR9","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.18632\/aging.203874","volume":"14","author":"X You","year":"2022","unstructured":"You, X. et al. Dihydroartemisinin attenuates pulmonary inflammation and fibrosis in rats by suppressing JAK2\/STAT3 signaling. Aging (Albany NY). 14, 1110\u20131127 (2022).","journal-title":"Aging (Albany NY)"},{"key":"20949_CR10","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1093\/jaoacint\/qsab010","volume":"104","author":"C You","year":"2021","unstructured":"You, C. et al. Homogenate extraction of Dihydroartemisinin from Artemisia hedinii and its antifungal activity. J. AOAC Int. 104, 1206\u20131212 (2021).","journal-title":"J. AOAC Int."},{"key":"20949_CR11","doi-asserted-by":"publisher","first-page":"722331","DOI":"10.3389\/fonc.2021.722331","volume":"11","author":"R Yu","year":"2021","unstructured":"Yu, R., Jin, G., Fujimoto, M. & Dihydroartemisinin A potential drug for the treatment of malignancies and inflammatory diseases. Front. Oncol. 11, 722331 (2021).","journal-title":"Front. Oncol."},{"key":"20949_CR12","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.lfs.2019.03.020","volume":"223","author":"B Zhang","year":"2019","unstructured":"Zhang, B. et al. Dihydroartemisinin attenuates renal fibrosis through regulation of fibroblast proliferation and differentiation. Life Sci. 223, 29\u201337 (2019).","journal-title":"Life Sci."},{"key":"20949_CR13","first-page":"682","volume":"21","author":"H Liu","year":"2023","unstructured":"Liu, H. et al. Dihydroartemisinin attenuates ischemia\/reperfusion-induced renal tubular senescence by activating autophagy. Chin. J. Nat. Med. 21, 682\u2013693 (2023).","journal-title":"Chin. J. Nat. Med."},{"key":"20949_CR14","doi-asserted-by":"publisher","first-page":"105871","DOI":"10.1016\/j.phrs.2021.105871","volume":"174","author":"C Gu","year":"2021","unstructured":"Gu, C. et al. Dihydroartemisinin ameliorates retinal vascular dysfunction in diabetes mellitus via the FASN\/Kmal-mTOR\/SREBP1 feedback loop. Pharmacol. Res. 174, 105871 (2021).","journal-title":"Pharmacol. Res."},{"key":"20949_CR15","doi-asserted-by":"publisher","first-page":"26","DOI":"10.2340\/jphs.v58.5775","volume":"58","author":"S Shi","year":"2023","unstructured":"Shi, S., Gong, Y., Hu, H., Peng, S. & Liu, J. Topical Dihydroartemisinin improves wound healing in diabetic mice. J. Plast. Surg. Hand Surg. 58, 26\u201332 (2023).","journal-title":"J. Plast. Surg. Hand Surg."},{"key":"20949_CR16","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s10020-023-00744-0","volume":"29","author":"Y Li","year":"2023","unstructured":"Li, Y. et al. CRTC2 activates the epithelial-mesenchymal transition of diabetic kidney disease through the CREB-Smad2\/3 pathway. Mol. Med. 29, 146 (2023).","journal-title":"Mol. Med."},{"key":"20949_CR17","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1007\/s00109-015-1301-3","volume":"93","author":"MK Kang","year":"2015","unstructured":"Kang, M. K., Park, S. H., Choi, Y. J., Shin, D. & Kang, Y. H. Chrysin inhibits diabetic renal tubulointerstitial fibrosis through blocking epithelial to mesenchymal transition. J. Mol. Med. (Berl). 93, 759\u2013772 (2015).","journal-title":"J. Mol. Med. (Berl)"},{"key":"20949_CR18","doi-asserted-by":"publisher","first-page":"848915","DOI":"10.3389\/fphar.2022.848915","volume":"13","author":"Z Xu","year":"2022","unstructured":"Xu, Z. et al. Gentiopicroside ameliorates diabetic renal tubulointerstitial fibrosis via inhibiting the AT1R\/CK2\/NF-kappaB pathway. Front. Pharmacol. 13, 848915 (2022).","journal-title":"Front. Pharmacol."},{"key":"20949_CR19","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s10020-022-00525-1","volume":"28","author":"Y Jia","year":"2022","unstructured":"Jia, Y. et al. Tubular epithelial cell-derived extracellular vesicles induce macrophage Glycolysis by stabilizing HIF-1alpha in diabetic kidney disease. Mol. Med. 28, 95 (2022).","journal-title":"Mol. Med."},{"key":"20949_CR20","doi-asserted-by":"publisher","first-page":"13299","DOI":"10.3390\/ijms222413299","volume":"22","author":"A Owczarek","year":"2021","unstructured":"Owczarek, A., Gieczewska, K. B., Jarzyna, R., Frydzinska, Z. & Winiarska, K. Transcription factor ChREBP mediates high Glucose-Evoked increase in HIF-1alpha content in epithelial cells of renal proximal tubules. Int. J. Mol. Sci. 22, 13299 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"20949_CR21","doi-asserted-by":"publisher","first-page":"2650","DOI":"10.1091\/mbc.e14-01-0044","volume":"25","author":"R Du","year":"2014","unstructured":"Du, R. et al. Hypoxia-induced Bmi1 promotes renal tubular epithelial cell-mesenchymal transition and renal fibrosis via PI3K\/Akt signal. Mol. Biol. Cell. 25, 2650\u20132659 (2014).","journal-title":"Mol. Biol. Cell."},{"key":"20949_CR22","doi-asserted-by":"publisher","first-page":"166081","DOI":"10.1016\/j.bbadis.2021.166081","volume":"1867","author":"F Zhu","year":"2021","unstructured":"Zhu, F. et al. Tubular numb promotes renal interstitial fibrosis via modulating HIF-1alpha protein stability. Biochim. Biophys. Acta Mol. Basis Dis. 1867, 166081 (2021).","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"20949_CR23","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1007\/s12011-016-0661-z","volume":"173","author":"X Zhang","year":"2016","unstructured":"Zhang, X. et al. Zinc attenuates tubulointerstitial fibrosis in diabetic nephropathy via Inhibition of HIF through PI-3K signaling. Biol. Trace Elem. Res. 173, 372\u2013383 (2016).","journal-title":"Biol. Trace Elem. Res."},{"key":"20949_CR24","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1111\/jdi.13478","volume":"12","author":"H Liu","year":"2021","unstructured":"Liu, H., Takagaki, Y., Kumagai, A., Kanasaki, K. & Koya, D. The PKM2 activator TEPP-46 suppresses kidney fibrosis via Inhibition of the EMT program and aberrant Glycolysis associated with suppression of HIF-1alpha accumulation. J. Diabetes Investig. 12, 697\u2013709 (2021).","journal-title":"J. Diabetes Investig"},{"key":"20949_CR25","doi-asserted-by":"publisher","first-page":"116730","DOI":"10.1016\/j.lfs.2019.116730","volume":"233","author":"W Zhu","year":"2019","unstructured":"Zhu, W. et al. Dihydroartemisinin suppresses Glycolysis of LNCaP cells by inhibiting PI3K\/AKT pathway and downregulating HIF-1alpha expression. Life Sci. 233, 116730 (2019).","journal-title":"Life Sci."},{"key":"20949_CR26","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1002\/ptr.8065","volume":"39","author":"Z Li","year":"2025","unstructured":"Li, Z. et al. Dihydroartemisinin inhibits melanoma migration and metastasis by affecting angiogenesis. Phytother Res. 39, 1679\u20131693 (2025).","journal-title":"Phytother Res."},{"key":"20949_CR27","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12943-024-02046-3","volume":"23","author":"F Liu","year":"2024","unstructured":"Liu, F. et al. Ubiquitination and deubiquitination in cancer: from mechanisms to novel therapeutic approaches. Mol. Cancer. 23, 148 (2024).","journal-title":"Mol. Cancer"},{"key":"20949_CR28","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1124\/mol.106.027029","volume":"70","author":"Q Ke","year":"2006","unstructured":"Ke, Q. & Costa, M. Hypoxia-inducible factor-1 (HIF-1). Mol. Pharmacol. 70, 1469\u20131480 (2006).","journal-title":"Mol. Pharmacol."},{"key":"20949_CR29","doi-asserted-by":"publisher","first-page":"167244","DOI":"10.1016\/j.jmb.2021.167244","volume":"433","author":"W He","year":"2021","unstructured":"He, W., Batty-Stuart, S., Lee, J. E. & Ohh, M. HIF-1alpha hydroxyprolines modulate Oxygen-Dependent protein stability via single VHL interface with comparable effect on ubiquitination rate. J. Mol. Biol. 433, 167244 (2021).","journal-title":"J. Mol. Biol."},{"key":"20949_CR30","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.freeradbiomed.2022.07.004","volume":"189","author":"X Cui","year":"2022","unstructured":"Cui, X. et al. GPR87 promotes renal tubulointerstitial fibrosis by accelerating Glycolysis and mitochondrial injury. Free Radic Biol. Med. 189, 58\u201370 (2022).","journal-title":"Free Radic Biol. Med."},{"key":"20949_CR31","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s10565-022-09711-7","volume":"39","author":"T Yang","year":"2023","unstructured":"Yang, T. et al. YY1 inactivated transcription co-regulator PGC-1alpha to promote mitochondrial dysfunction of early diabetic nephropathy-associated tubulointerstitial fibrosis. Cell. Biol. Toxicol. 39, 391\u2013413 (2023).","journal-title":"Cell. Biol. Toxicol."},{"key":"20949_CR32","doi-asserted-by":"publisher","first-page":"117863","DOI":"10.1016\/j.jep.2024.117863","volume":"328","author":"Z Qiyan","year":"2024","unstructured":"Qiyan, Z. et al. JinChan YiShen TongLuo formula ameliorate mitochondrial dysfunction and apoptosis in diabetic nephropathy through the HIF-1alpha-PINK1-Parkin pathway. J. Ethnopharmacol. 328, 117863 (2024).","journal-title":"J. Ethnopharmacol."},{"key":"20949_CR33","doi-asserted-by":"publisher","first-page":"e12909","DOI":"10.1111\/cpr.12909","volume":"53","author":"N Jiang","year":"2020","unstructured":"Jiang, N. et al. HIF-1alpha ameliorates tubular injury in diabetic nephropathy via HO-1-mediated control of mitochondrial dynamics. Cell. Prolif. 53, e12909 (2020).","journal-title":"Cell. Prolif."},{"key":"20949_CR34","first-page":"17","volume":"20","author":"Y Wang","year":"2020","unstructured":"Wang, Y. et al. Metformin attenuates renal interstitial fibrosis through upregulation of deptor in unilateral ureteral obstruction in rats. Exp. Ther. Med. 20, 17 (2020).","journal-title":"Exp. Ther. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20949-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20949-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20949-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T06:33:24Z","timestamp":1759300404000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20949-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,30]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["20949"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-20949-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,30]]},"assertion":[{"value":"7 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Experiments were confirmed by Ethics Committee of Tongxiang First People\u2019s Hospital. All methods were performed in accordance with ARRIVE guidelines ().","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declarations"}}],"article-number":"34106"}}